AHK-Cu
AHK-Cu

£19.99

Read more This product has multiple variants. The options may be chosen on the product page

AHK-Cu

£19.99

  • UK Stock
  • Secure Payments
  • Discreet UK Delivery

AHK-Cu is an alanine–histidine–lysine copper(II) complex supplied as lyophilised material for laboratory research in hair-follicle and dermal papilla cell models.

AHK-Cu
This item: AHK-Cu
£19.99
£19.99
Bacteriostatic Water - 3ml
Bacteriostatic Water - 3ml

In stock

£3.99
MOTS-c - 10mg
MOTS-c - 10mg

In stock

£24.99
1 Vial
£19.99
1 Vial
£17.99 Save 10%
3 Vials
£16.99 Save 15%
5 Vials
£15.99 Save 20%

For in vitro laboratory research only.
Not for human or veterinary use. Not for diagnosis, treatment, cure, or prevention of any disease. No dosage, administration, or injection guidance is provided.

This product is currently sold out!

No worries! Please enter your e-mail address and we will promptly notify you as soon as the item is back in stock.

Great! You have been added to the waitlist for this product. Please check your inbox and confirm the subscription to this waitlist.

AHK-Cu is a copper(II) complex of the tripeptide L-alanyl-L-histidyl-L-lysine (Ala–His–Lys). It has been investigated in cultured dermal papilla cells and isolated human hair follicles, and is supplied as a lyophilised research material.

Research material only

This material is not supplied as a medicine, treatment, cosmetic, supplement or consumer product. It is not for human or veterinary use, consumption or administration, and is not intended to diagnose, treat, cure or prevent any disease.

Compound overview

CompoundAHK-Cu
Peptide sequenceAla–His–Lys (AHK)
Research classCopper-binding tripeptide complex
Metal componentCopper(II)
FormLyophilised material

Research context

A 2007 study examined AHK-Cu in cell culture and isolated human hair follicles. These preclinical models do not establish hair-growth benefits or safety in people. See the Research tab for the primary publication and its limitations.

Batch documentation

Independent analytical documentation is published where available for specific batches and variations. A result indicator appears only when a published record is available. Match the vial size and batch identifier to the corresponding report before relying on any result.

Browse available lab results →

Supply and laboratory handling

  • Supplied in the vial size selected above.
  • Keep the sealed lyophilised vial dry and protected from direct light.
  • A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, compound-specific information and your laboratory’s validated procedure.
  • Use clean laboratory technique and equipment appropriate to the intended analytical method.
  • Follow the lot-specific documentation and your laboratory’s validated handling and storage procedures.
  • Avoid repeated temperature cycling and unnecessary exposure to moisture.

Where a batch document or supplier specification gives different instructions, the lot-specific document takes precedence.

Frequently asked questions

What is AHK-Cu?

AHK-Cu is a copper(II) complex of the tripeptide L-alanyl-L-histidyl-L-lysine. Its peptide sequence is Ala–His–Lys.

Is this AHK-Cu supplied as a medicine or cosmetic?

No. This material is supplied solely for controlled laboratory research. It is not supplied as a medicine, treatment, cosmetic, supplement or consumer product.

Which vial sizes are available?

Current vial sizes, stock, pre-order status, pricing and any batch-documentation indicators are shown in the variation selector above.

Does every vial size have a published laboratory result?

No. Results are available only for the selected batches and vial sizes marked with a result indicator. Always check the batch identifier on the report.

How should the material be stored?

Keep the sealed lyophilised material dry and protected from light. A cool, dry place, refrigerator or freezer may be used according to the intended storage duration, compound-specific information and your laboratory’s validated procedure. Avoid repeated temperature cycling and moisture exposure. No universal shelf-life is stated unless it is supported by batch documentation.

Information reviewed: 18 October 2026.

Size

50mg

Batch-specific analytical documentation

Independent analytical results are published for selected Havoc Labs products, vial sizes and batches. The result attached to one variation must not be treated as evidence for a different size or batch.

  • Result available: a published report is available for the marked variation.
  • Test pending: a sample has been submitted, but no completed result is being claimed.
  • No indicator: no product-specific result is currently displayed for that variation.

Check the identifiers

Always match the compound, vial size and batch reference on the product to the corresponding laboratory record. Where the laboratory provides an independent verification facility, use it to confirm the report.

Browse published lab results →

Storage and stability

Storage requirements can vary by compound, physical form, intended storage duration and batch. Follow the lot-specific documentation and your laboratory’s validated procedure wherever these are available.

Form Suggested storage Important note
Sealed lyophilised material Keep in a cool, dry place, refrigerated at 2–8°C or frozen, as appropriate for the compound and intended storage period. Keep sealed, dry and protected from direct light. Follow compound- and batch-specific documentation and avoid repeated temperature cycling.
Reconstituted solution Refrigerate at 2–8°C unless the applicable laboratory protocol specifies otherwise. Stability depends on the preparation conditions, solvent, concentration, container and handling. No universal storage period is claimed.

No universal shelf-life is claimed

Do not assume a fixed expiry or prepared-solution storage period unless it is supported by relevant stability data or batch documentation. Where a lot-specific document gives different instructions, that document takes precedence.

Published AHK-Cu research

  1. The effect of tripeptide-copper complex on human hair growth in vitro. Archives of Pharmacal Research, 2007;30(7):834–839. DOI: 10.1007/BF02978833. View on PubMed ↗

The researchers reported increased follicle elongation ex vivo and dermal papilla cell proliferation in vitro. Bcl-2/Bax increased and cleaved caspase-3 and PARP decreased. However, the reduction in apoptotic cells was not statistically significant.

Preclinical evidence

This was laboratory research, not a clinical trial in people. It does not establish a treatment for hair loss, human safety, or the identity, purity or performance of this product. Published research is separate from lot-specific analytical documentation. Research use only; not for human or veterinary use.

References reviewed 18 October 2026.